Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-13
Closed -$1.95K 936
2024
Q4
$1.95K Hold
13
﹤0.01% 850
2024
Q3
$2.13K Hold
13
﹤0.01% 839
2024
Q2
$1.8K Hold
13
﹤0.01% 857
2024
Q1
$1.79K Hold
13
﹤0.01% 829
2023
Q4
$1.36K Hold
13
﹤0.01% 811
2023
Q3
$1.23K Hold
13
﹤0.01% 811
2023
Q2
$1.31K Hold
13
﹤0.01% 756
2023
Q1
$1.05K Hold
13
﹤0.01% 762
2022
Q4
$971 Buy
13
+5
+63% +$388 ﹤0.01% 744
2022
Q3
$1K Hold
8
﹤0.01% 732
2022
Q2
$1K Hold
8
﹤0.01% 689
2022
Q1
$1K Buy
+8
New +$898 ﹤0.01% 696
2021
Q4
Sell
-8
Closed -$1K 221
2021
Q3
$1K Buy
+8
New +$1K ﹤0.01% 677

Other funds holding DVA

MCF Advisors's DVA Position: Q1 2025 in Review

MCF Advisors sold out of DaVita (DVA) in Q1 2025, closing a stake of 13 shares — an estimated $1.95K sold.

MCF Advisors first reported a position in DVA in Q3 2021 and held it in 13 quarters. The position peaked at $2.13K in Q3 2024. 597 funds tracked by Wall St. Rank hold DVA as of Q1 2025.

  • MCF Advisors reported no remaining DaVita position as of Q1 2025 after selling out during the quarter.
  • MCF Advisors sold 13 DaVita shares in Q1 2025, an estimated $1.95K.
  • MCF Advisors first reported a position in DaVita in Q3 2021 and held it in 13 quarters.
  • MCF Advisors's DaVita position peaked at $2.13K in Q3 2024.
  • 597 funds tracked by Wall St. Rank held DaVita as of Q1 2025.

Based on MCF Advisors's 13F filing for Q1 2025, filed 6 May 2025.